Germany Life Sciences Market Segmentation
Life Sciences By Type (USD Million, 2025-2035)
- Abortive Drugs
- Preventive Drugs
- CGRP Inhibitors
- Triptans
Life Sciences By Route of Administration (USD Million, 2025-2035)
- Oral
- Injectable
- Nasal
Life Sciences By Therapeutic Class (USD Million, 2025-2035)
- NSAIDs
- Ergots
- Beta Blockers
- Antidepressants
Life Sciences By Patient Demographics (USD Million, 2025-2035)
- Adults
- Children
- Geriatrics